CG Oncology Management
Management criteria checks 2/4
CG Oncology's CEO is Arthur Kuan, appointed in Jan 2017, has a tenure of 7.42 years. total yearly compensation is $3.93M, comprised of 11.4% salary and 88.6% bonuses, including company stock and options. directly owns 0.054% of the company’s shares, worth $1.10M. The average tenure of the management team and the board of directors is 0.8 years and 5.7 years respectively.
Key information
Arthur Kuan
Chief executive officer
US$3.9m
Total compensation
| CEO salary percentage | 11.4% |
| CEO tenure | 7.4yrs |
| CEO ownership | 0.05% |
| Management average tenure | less than a year |
| Board average tenure | 5.7yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$72m |
| Dec 31 2023 | US$4m | US$449k | -US$68m |
| Sep 30 2023 | n/a | n/a | -US$58m |
| Dec 31 2022 | US$1m | US$394k | -US$44m |
Compensation vs Market: Arthur's total compensation ($USD3.93M) is below average for companies of similar size in the US market ($USD5.68M).
Compensation vs Earnings: Arthur's compensation has increased whilst the company is unprofitable.
CEO
Arthur Kuan (33 yo)
7.4yrs
Tenure
US$3,933,996
Compensation
Mr. Arthur Kuan serves as Chief Executive Officer and Director at CG Oncology, Inc. since 2017 and also serves as its Chairman since December 2023. Mr. Kuan served as the Chief Operating Officer of CG Onco...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 7.4yrs | US$3.93m | 0.054% $ 1.1m | |
| President & COO | less than a year | US$3.03m | 0% $ 0 | |
| Chief Medical Officer | less than a year | US$2.44m | 0.0020% $ 40.1k | |
| CFO & Secretary | less than a year | no data | 0.0030% $ 61.0k | |
| Vice President of Finance | 2.4yrs | no data | no data | |
| Chief Technical Officer | less than a year | no data | no data | |
| Vice President of Corporate Development | no data | no data | no data |
0.8yrs
Average Tenure
54.5yo
Average Age
Experienced Management: CGON's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 7.4yrs | US$3.93m | 0.054% $ 1.1m | |
| Lead Independent Director | 5.7yrs | US$77.54k | 0% $ 0 | |
| Independent Director | less than a year | no data | no data | |
| Member of Chemistry | no data | no data | no data | |
| Member of Chemistry | no data | no data | no data | |
| Independent Director | 5.7yrs | US$198.00k | 0% $ 0 | |
| Independent Director | less than a year | US$599.04k | no data | |
| Member of Chemistry | no data | no data | no data | |
| Independent Director | 8.6yrs | no data | 6.82% $ 138.7m | |
| Independent Director | 1.8yrs | no data | no data | |
| Member of Chemistry | no data | no data | no data |
5.7yrs
Average Tenure
57yo
Average Age
Experienced Board: CGON's board of directors are considered experienced (5.7 years average tenure).